A comparison of overlapping promoter sequences between mouse tumor regulated genes and ChIP sequencing data for 7 different human and 2 murine cell lines confirmed 94% and 91%, respectively to be c-Myc bona fide targets (Supplementary Table S7), thus supporting the notion for c-Myc to be a key regulator of cell metabolism. This evidence concerns the gene MYC and neoplasm.